スキンブースターの世界市場：市場規模・シェア・動向分析 (種類別・性別・最終用途別・成分別・地域別)、セグメント別予測 (2025年～2030年)

スキンブースター市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のスキンブースターの市場規模は2025年から2030年にかけて13.0%のCAGRを記録し、2030年までに28億2,000万米ドルに達すると予測されています。

ヒアルロン酸、ビタミン、ミネラル、抗酸化物質など、体内で自然に生成される生体適合性化合物を表皮や中胚葉に注入する方法です。また、これは単に水分補給のプロセスを助けるだけであり、若々しく輝くための基本です。

ダーマフィラーとは異なり、スキンブースターはシワの減少や増強のためのものではなく、その役割は主に皮膚に潤いを与え、新しいコラーゲンとエラスチンの形成を促進し、皮膚にハリを与えることです。美容技術の進歩、可処分所得の増加、美意識の高まり、自然な輝きを求める老人人口の増加などの要因が、市場の成長を促進しています。Galderma社によると、Restylane Skinboostersの治療は現在までに500万件以上行われています。

顔の特徴を歪ませたり、プロポーションを崩したりすることなく、自然な輝きを与えるという事実により、需要は大きく伸びると予想されます。ソーシャルメディアの影響力の増大、美的外観に対する高い意識、個人の自信や自己イメージとの関連は、市場成長の理由の一部です。

COVID-19の影響により、外科治療のための患者の予約が一時的に停止したため、市場は妨げられました。しかし、多くの国で政府が選択的美容施術の再開を認めて以来、需要は増加傾向にあります。さらにBBCネットワークによると、パンデミック後、多くの外科的・非外科的美容治療に対する問い合わせや予約が急増しており、市場成長の促進が期待されています。

スキンブースター市場：分析概要

• メソセラピーが市場をリードし、2024年の世界売上高の54.6%を占めています。メソセラピーは、個々のスキンケア問題に対処するためにカスタマイズされた治療アプローチを提供することでパーソナライゼーションを高めます。
• ヒアルロン酸（HA）スキンブースターが市場をリードし、2024年の売上高シェアは54.9%でした。スキンブースター市場は、HAのユニークな特性と利点により大きな成長を示しています。
• 2024年には、女性セグメントが最大の市場収益シェアを占めました。これは、女性がホルモンの変動や関連する懸念事項により、老化やくすみの兆候を早期に示すことが主な理由です。
• 2024年には、メディカルスパ・セグメンテーションが市場を独占しました。スキンブースターの施術は、患者のダウンタイムが短く、美容整形手術の非侵襲的な性質のため、主にメディカルスパで行われています。
• 北米のスキンブースター市場は2024年に29.5%のシェアを占めました。アジア太平洋のスキンブースター市場は、予測期間中に14.7％のCAGRで最速の成長が見込まれています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 スキンブースター市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• スキンブースター市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析

第4章 スキンブースター市場：種類別の推定・動向分析

• 市場シェア：モダリティ別 (2024年・2030年)
• セグメントダッシュボード
• 世界のスキンブースター市場の展望：モダリティ別
• 市場規模の予測と動向分析 (2018～2030年)
  • メソセラピー
  • マイクロニードル

第5章 スキンブースター市場：成分別の推定・動向分析

• 市場シェア：成分別 (2024年・2030年)
• セグメントダッシュボード
• 世界のスキンブースター市場の展望：成分別
• 市場規模の予測と動向分析 (2018～2030年)
  • ヒアルロン酸（HA）
  • ポリデオキシリボヌクレオチド（PDRN）
  • ポリ-L-乳酸（PLLA）/ポリ-D,L-乳酸（PDLLA）
  • ポリカプロラクトン（PCL）
  • エクソソーム

第6章 スキンブースター市場：性別の推定・動向分析

• 市場シェア：性別 (2024年・2030年)
• セグメントダッシュボード
• 世界のスキンブースター市場の展望：性別
• 市場規模の予測と動向分析 (2018～2030年)
  • 女性
  • 男性

第7章 スキンブースター市場：最終用途別の推定・動向分析

• 市場シェア：最終用途別 (2024年・2030年)
• セグメントダッシュボード
• 世界のスキンブースター市場の展望：最終用途別
• 市場規模の予測と動向分析 (2018～2030年)
  • 皮膚科クリニック
  • メディスパ

第8章 スキンブースター市場：地域別の推定・動向分析

• 市場シェア：地域別 (2024年・2030年)
• 市場ダッシュボード：地域別
• 世界のスキンブースター市場の展望：地域別
• 市場規模の予測と動向分析 (2018～2030年)
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 最近の動向と影響分析：主要な市場参入企業別
• 企業/競合の分類
• ベンダー情勢
  • 主要な販売代理店およびチャネルパートナーのリスト
  • Key customers
  • Key company market share analysis, 2024
  • AbbVie, Inc（Allergen）
  • Galderma
  • Sinclair
  • Merz Pharma
  • Teoxane
  • Medytox, Inc.
  • PharmaResearch Co., Ltd.
  • VAIM Co., Ltd
  • Bloomage Biotechnology
  • IBSA Farmaceutici Italia Srl
  • Dexlevo Co., Ltd.
  • LINKUS GLOBAL Co., Ltd.
  • ExoCoBio Inc.

List of Tables

• Table 1 List of abbreviation
• Table 2 North America Skin Boosters market, by region, 2018 - 2030 (USD Million)
• Table 3 North America Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 4 North America Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 5 North America Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 6 North America Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 7 U.S. Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 8 U.S. Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 9 U.S. Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 10 U.S. Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 11 Canada Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 12 Canada Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 13 Canada Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 14 Canada Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 15 Mexico Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 16 Mexico Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 17 Mexico Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 18 Mexico Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 19 Europe Skin Boosters market, by region, 2018 - 2030 (USD Million)
• Table 20 Europe Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 21 Europe Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 22 Europe Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 23 Europe Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 24 Germany Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 25 Germany Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 26 Germany Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 27 Germany Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 28 UK Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 29 UK Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 30 UK Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 31 UK Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 32 France Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 33 France Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 34 France Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 35 France Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 36 Italy Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 37 Italy Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 38 Italy Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 39 Italy Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 40 Spain Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 41 Spain Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 42 Spain Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 43 Spain Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 44 Denmark Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 45 Denmark Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 46 Denmark Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 47 Denmark Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 48 Sweden Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 49 Sweden Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 50 Sweden Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 51 Sweden Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 52 Norway Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 53 Norway Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 54 Norway Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 55 Norway Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 56 Asia Pacific Skin Boosters market, by region, 2018 - 2030 (USD Million)
• Table 57 Asia Pacific Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 61 China Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 62 China Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 63 China Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 64 China Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 65 Japan Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 66 Japan Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 67 Japan Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 68 Japan Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 69 India Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 70 India Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 71 India Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 72 India Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 73 Australia Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 74 Australia Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 75 Australia Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 76 Australia Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 77 South Korea Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 78 South Korea Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 79 South Korea Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 80 South Korea Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 81 Thailand Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 82 Thailand Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 83 Thailand Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 84 Thailand Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 85 Latin America Skin Boosters market, by region, 2018 - 2030 (USD Million)
• Table 86 Latin America Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 87 Latin America Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 88 Latin America Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 89 Latin America Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 90 Brazil Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 91 Brazil Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 92 Brazil Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 93 Brazil Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 94 Argentina Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 95 Argentina Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 96 Argentina Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 97 Argentina Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 98 MEA Skin Boosters market, by region, 2018 - 2030 (USD Million)
• Table 99 MEA Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 100 MEA Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 101 MEA Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 102 MEA Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 103 South Africa Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 104 South Africa Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 105 South Africa Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 106 South Africa Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 110 Saudi Arabia Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 111 UAE Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 112 UAE Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 113 UAE Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 114 UAE Skin Boosters market, by end-use, 2018 - 2030 (USD Million)
• Table 115 Kuwait Skin Boosters market, by type, 2018 - 2030 (USD Million)
• Table 116 Kuwait Skin Boosters market, by ingredient, 2018 - 2030 (USD Million)
• Table 117 Kuwait Skin Boosters market, by gender, 2018 - 2030 (USD Million)
• Table 118 Kuwait Skin Boosters market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Skin Boosters market: market outlook
• Fig. 14 Skin Boosters competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Skin Boosters market driver impact
• Fig. 20 Skin Boosters market restraint impact
• Fig. 21 Skin Boosters market strategic initiatives analysis
• Fig. 22 Skin Boosters market: Type movement analysis
• Fig. 23 Skin Boosters market: Type outlook and key takeaways
• Fig. 24 Mesotherapy market estimates and forecast, 2018 - 2030
• Fig. 25 Micro-needle estimates and forecast, 2018 - 2030
• Fig. 26 Skin Boosters market: Ingredient movement analysis
• Fig. 27 Skin Boosters market: Ingredient outlook and key takeaways
• Fig. 28 Hyaluronic acid (HA) market estimates and forecast, 2018 - 2030
• Fig. 29 Polydeoxyribonucleotides (PDRN) estimates and forecast, 2018 - 2030
• Fig. 30 Poly-L-Lactic Acid (PLLA)/ Poly-D, L-Lactic Acid (PDLLA) estimates and forecast, 2018 - 2030
• Fig. 31 Polycaprolactone (PCL) estimates and forecast, 2018 - 2030
• Fig. 32 Exosomes estimates and forecast, 2018 - 2030
• Fig. 33 Skin Boosters Market: Gender movement Analysis
• Fig. 34 Skin Boosters market: Gender outlook and key takeaways
• Fig. 35 Female market estimates and forecasts, 2018 - 2030
• Fig. 36 Male market estimates and forecasts, 2018 - 2030
• Fig. 37 Skin Boosters market: end-use movement analysis
• Fig. 38 Skin Boosters market: end-use outlook and key takeaways
• Fig. 39 Dermatology clinics market estimates and forecasts, 2018 - 2030
• Fig. 40 Medspas market estimates and forecasts, 2018 - 2030
• Fig. 41 Global Skin Boosters market: Regional movement analysis
• Fig. 42 Global Skin Boosters market: Regional outlook and key takeaways
• Fig. 43 Global Skin Boosters market share and leading players
• Fig. 44 North America, by country
• Fig. 45 North America
• Fig. 46 North America market estimates and forecasts, 2018 - 2030
• Fig. 47 U.S.
• Fig. 48 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 49 Canada
• Fig. 50 Canada market estimates and forecasts, 2018 - 2030
• Fig. 51 Mexico
• Fig. 52 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 53 Europe
• Fig. 54 Europe market estimates and forecasts, 2018 - 2030
• Fig. 55 UK
• Fig. 56 UK market estimates and forecasts, 2018 - 2030
• Fig. 57 Germany
• Fig. 58 Germany market estimates and forecasts, 2018 - 2030
• Fig. 59 France
• Fig. 60 France market estimates and forecasts, 2018 - 2030
• Fig. 61 Italy
• Fig. 62 Italy market estimates and forecasts, 2018 - 2030
• Fig. 63 Spain
• Fig. 64 Spain market estimates and forecasts, 2018 - 2030
• Fig. 65 Denmark
• Fig. 66 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 67 Sweden
• Fig. 68 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 69 Norway
• Fig. 70 Norway market estimates and forecasts, 2018 - 2030
• Fig. 71 Asia Pacific
• Fig. 72 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 73 China
• Fig. 74 China market estimates and forecasts, 2018 - 2030
• Fig. 75 Japan
• Fig. 76 Japan market estimates and forecasts, 2018 - 2030
• Fig. 77 India
• Fig. 78 India market estimates and forecasts, 2018 - 2030
• Fig. 79 Australia
• Fig. 80 Australia market estimates and forecasts, 2018 - 2030
• Fig. 81 South Korea
• Fig. 82 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 83 Thailand
• Fig. 84 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 85 Latin America
• Fig. 86 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 87 Brazil
• Fig. 88 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 89 Argentina
• Fig. 90 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 91 Middle East and Africa
• Fig. 92 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 93 South Africa
• Fig. 94 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 95 Saudi Arabia
• Fig. 96 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 97 UAE
• Fig. 98 UAE market estimates and forecasts, 2018 - 2030
• Fig. 99 Kuwait
• Fig. 100 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 101 Market share of key market players- Skin Boosters market

Skin Boosters Market Growth & Trends:

The global skin boosters market size is expected to reach USD 2.82 billion by 2030, registering a CAGR of 13.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Under this procedure wherein microinjections of biocompatible compounds like hyaluronic acid, vitamins, minerals, and anti-oxidants, etc. that are naturally produced by the body are injected into the epidermis or mesoderm. Also, this simply helps aid in the hydration process, which is fundamental for a youthful glow.

Unlike dermal fillers, skin boosters are not for wrinkle reduction or augmentation, their role is to primarily hydrate the skin and promote the formation of new collagen and elastin to give the skin a firmer appearance. Factors like rising technological advancement in aesthetics, rising disposable income, increasing aesthetic consciousness, and the increasing geriatric population in the search for a natural glow are propelling the market growth. According to Galderma, over five million treatments of Restylane Skinboosters have been performed to date.

The demand is expected to propel significantly due to the fact that it provides a natural glow without distorting facial features or making them appear out of proportion. Growing social media influence, high consciousness towards aesthetic appearance, and its association with self-confidence and self-image by an individual are some of the reasons for market growth.

In the light of COVID-19, the market was hampered as the footfall of patient appointments for surgical treatments was temporarily suspended. However, since the government in many countries has allowed resuming elective aesthetic procedures the demand has been on the rise. Moreover, according to the BBC network, inquiries and appointments for many surgical and non-surgical cosmetic treatments have seen a surge following the pandemic and are thus expected to propel market growth.

Skin Boosters Market Report Highlights:

• Mesotherapy led the market and accounted for 54.6% of the global revenue in 2024. Mesotherapy elevates personalization by providing a customized treatment approach to address individual skincare issues.
• Hyaluronic acid (HA) skin boosters led the market with a revenue share of 54.9% in 2024. The skin boosters market has witnessed significant growth due to the unique properties and benefits of HA.
• The female segment accounted for the largest market revenue share in 2024. This is because women show early signs of aging and dullness majorly due to hormonal fluctuations and related concerns.
• Medical spa segment dominated the market in 2024. Skin booster procedures are primarily performed by medspas owing to low patient downtime and non-invasive nature of cosmetic surgery.
• North America skin boosters market dominated and accounted for 29.5% share in 2024. The Asia Pacific skin boosters market is anticipated to grow with the fastest CAGR of 14.7% during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Ingredient
  • 1.2.3. Gender
  • 1.2.4. End-use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Ingredient outlook
  • 2.2.3. Gender outlook
  • 2.2.4. End-use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Skin Boosters Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing preference for minimally invasive procedures
    • 3.2.1.2. Increasing public awareness towards aesthetic procedures
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent regulations & approvals
    • 3.2.2.2. Lack of reimbursement
• 3.3. Skin Boosters Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Skin Boosters Market: Type Estimates & Trend Analysis

• 4.1. Type Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Skin Boosters Market by Type Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Mesotherapy
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Micro-needle
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Skin Boosters Market: Ingredient Estimates & Trend Analysis

• 5.1. Ingredient Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Skin Boosters Market by Ingredient Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Hyaluronic acid (HA)
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Polydeoxyribonucleotides (PDRN)
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Poly-L-Lactic Acid (PLLA)/ Poly-D, L-Lactic Acid (PDLLA)
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Polycaprolactone (PCL)
    • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Exosomes
    • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Skin Boosters Market: Gender Estimates & Trend Analysis

• 6.1. Gender Market Share, 2024 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Skin Boosters Market by Gender Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Female
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Male
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Skin Boosters Market: End-use Estimates & Trend Analysis

• 7.1. End-use Market Share, 2024 & 2030
• 7.2. Segment Dashboard
• 7.3. Global Skin Boosters Market by End-use Outlook
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.4.1. Dermatology Clinics
    • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Medspas
    • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Skin Boosters Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Mexico
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework/ reimbursement structure
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework/ reimbursement structure
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Denmark
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework/ reimbursement structure
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Regulatory framework/ reimbursement structure
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.8. Norway
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Regulatory framework/ reimbursement structure
    • 8.6.8.3. Competitive scenario
    • 8.6.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Regulatory framework/ reimbursement structure
    • 8.7.5.3. Competitive scenario
    • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Regulatory framework/ reimbursement structure
    • 8.7.6.3. Competitive scenario
    • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Regulatory framework/ reimbursement structure
    • 8.8.1.3. Competitive scenario
    • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework/ reimbursement structure
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Regulatory framework/ reimbursement structure
    • 8.9.1.3. Competitive scenario
    • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Regulatory framework/ reimbursement structure
    • 8.9.2.3. Competitive scenario
    • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Regulatory framework/ reimbursement structure
    • 8.9.3.3. Competitive scenario
    • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Regulatory framework/ reimbursement structure
    • 8.9.4.3. Competitive scenario
    • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2024
  • 9.3.4. AbbVie, Inc (Allergen)
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Galderma
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Sinclair
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Merz Pharma
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Teoxane
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Medytox, Inc.
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. PharmaResearch Co., Ltd.
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. VAIM Co., Ltd
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Bloomage Biotechnology
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. IBSA Farmaceutici Italia Srl
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Product benchmarking
    • 9.3.13.4. Strategic initiatives
  • 9.3.14. Dexlevo Co., Ltd.
    • 9.3.14.1. Company overview
    • 9.3.14.2. Financial performance
    • 9.3.14.3. Product benchmarking
    • 9.3.14.4. Strategic initiatives
  • 9.3.15. LINKUS GLOBAL Co., Ltd.
    • 9.3.15.1. Company overview
    • 9.3.15.2. Financial performance
    • 9.3.15.3. Product benchmarking
    • 9.3.15.4. Strategic initiatives
  • 9.3.16. ExoCoBio Inc.
    • 9.3.16.1. Company overview
    • 9.3.16.2. Financial performance
    • 9.3.16.3. Product benchmarking
    • 9.3.16.4. Strategic initiatives